CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 591390-591595 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T67745","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1287","span":{"begin":0,"end":205},"obj":"Epistemic_statement"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T297","span":{"begin":0,"end":205},"obj":"Sentence"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1293","span":{"begin":183,"end":196},"obj":"Phenotype"}],"attributes":[{"id":"A1293","pred":"hp_id","subj":"T1293","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2476","span":{"begin":66,"end":68},"obj":"Body_part"}],"attributes":[{"id":"A2476","pred":"uberon_id","subj":"T2476","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3691","span":{"begin":46,"end":64},"obj":"Disease"},{"id":"T3692","span":{"begin":66,"end":68},"obj":"Disease"},{"id":"T3693","span":{"begin":74,"end":94},"obj":"Disease"},{"id":"T3694","span":{"begin":96,"end":99},"obj":"Disease"},{"id":"T3695","span":{"begin":183,"end":204},"obj":"Disease"},{"id":"T3669","span":{"begin":46,"end":64},"obj":"Disease"},{"id":"T75441","span":{"begin":66,"end":68},"obj":"Disease"},{"id":"T33371","span":{"begin":74,"end":94},"obj":"Disease"},{"id":"T52629","span":{"begin":96,"end":99},"obj":"Disease"},{"id":"T85529","span":{"begin":183,"end":204},"obj":"Disease"}],"attributes":[{"id":"A3691","pred":"mondo_id","subj":"T3691","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A3692","pred":"mondo_id","subj":"T3692","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A3693","pred":"mondo_id","subj":"T3693","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"id":"A3694","pred":"mondo_id","subj":"T3694","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"id":"A3695","pred":"mondo_id","subj":"T3695","obj":"http://purl.obolibrary.org/obo/MONDO_0002562"},{"id":"A46430","pred":"mondo_id","subj":"T3669","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A58215","pred":"mondo_id","subj":"T75441","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A29396","pred":"mondo_id","subj":"T33371","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"id":"A59347","pred":"mondo_id","subj":"T52629","obj":"http://purl.obolibrary.org/obo/MONDO_0019100"},{"id":"A14705","pred":"mondo_id","subj":"T85529","obj":"http://purl.obolibrary.org/obo/MONDO_0002562"}],"text":"There is ongoing discussion regarding whether multiple sclerosis (MS) and neuromyelitis optica (NMO) should be considered as distinct disease entities, or represent the spectrum of a demyelinating disease."}